Ocular HSV-1 Latency, Reactivation and Recurrent DiseaseHassanain S. Toma, James M. Hill, Andrea Murina et al.|Seminars in Ophthalmology|2008Cited by 142
Ocular Herpes Simplex Virus: How are Latency, Reactivation, Recurrent Disease and Therapy Interrelated?Lena J Al-Dujaili, James M. Hill, Patrick P Clerkin et al.|Future Microbiology|2011Cited by 116
Drug delivery to the posterior segment of the eye for pharmacologic therapyShalin Shah, James M. Hill, Lori Vidal Denham et al.|Expert Review of Ophthalmology|2010Cited by 99
Rabbit and Mouse Models of HSV-1 Latency, Reactivation, and Recurrent Eye DiseasesJody M. Webre, Hilary W. Thompson, James M. Hill et al.|BioMed Research International|2012Cited by 91
Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cellsWalter J. Lukiw, James M. Hill, Jian Cui et al.|Neuroreport|2010Cited by 79